<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>While animal data suggest a protective effect of <z:chebi fb="111" ids="27732">caffeine</z:chebi> on cognition, studies in humans remain inconsistent </plain></SENT>
<SENT sid="1" pm="."><plain>We examined associations of coffee and <z:chebi fb="111" ids="27732">caffeine</z:chebi> intake in midlife with risk of <z:hpo ids='HP_0000726'>dementia</z:hpo>, its neuropathologic correlates, and <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> among 3494 men in the Honolulu-Asia Aging Study (mean age 52 at cohort entry, 1965-1968) examined for <z:hpo ids='HP_0000726'>dementia</z:hpo> in 1991-1993, including 418 decedents (1992-2004) who underwent brain autopsy </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="111" ids="27732">Caffeine</z:chebi> intake was determined according to self-reported coffee, tea, and cola consumption at baseline </plain></SENT>
<SENT sid="3" pm="."><plain>Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for overall <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD), <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (Cognitive Abilities Screening Instrument score &lt;74), and neuropathologic lesions at <z:hpo ids='HP_0011420'>death</z:hpo> (Alzheimer lesions, microvascular ischemic lesions, cortical <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo>, hippocampal <z:mp ids='MP_0000612'>sclerosis</z:mp>, generalized <z:mpath ids='MPATH_127'>atrophy</z:mpath>), according to coffee and <z:chebi fb="111" ids="27732">caffeine</z:chebi> intake </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000726'>Dementia</z:hpo> was diagnosed in 226 men (including 118 AD, 80 VaD), and <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> in 347 </plain></SENT>
<SENT sid="5" pm="."><plain>There were no significant associations between coffee or <z:chebi fb="111" ids="27732">caffeine</z:chebi> intake and risk of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, overall <z:hpo ids='HP_0000726'>dementia</z:hpo>, AD, VaD, or moderate/high levels of the individual neuropathologic lesion types </plain></SENT>
<SENT sid="6" pm="."><plain>However, men in the highest quartile of <z:chebi fb="111" ids="27732">caffeine</z:chebi> intake (&gt;277.5 mg/d) were less likely than men in the lowest quartile (â‰¤115.5 mg) to have any of the lesion types (adjusted-OR, 0.45; 95% CI, 0.23-0.89; p, trend = 0.04) </plain></SENT>
<SENT sid="7" pm="."><plain>Coffee and <z:chebi fb="111" ids="27732">caffeine</z:chebi> intake in midlife were not associated with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, <z:hpo ids='HP_0000726'>dementia</z:hpo>, or individual neuropathologic lesions, although higher <z:chebi fb="111" ids="27732">caffeine</z:chebi> intake was associated with a lower odds of having any of the lesion types at autopsy </plain></SENT>
</text></document>